- Full text PDF available (2)
- This year (2)
- Last 5 years (2)
- Last 10 years (2)
Journals and Conferences
Following our recent discovery of a new scaffold exhibiting significant neurotrophic and neurogenic activities, a structurally tweaked analogue, embodying a 2-oxa-spiro [5.4]decane framework, has been conceptualised and found to be more potent and versatile. It exhibits enhanced neurotrophic and neurogenic action in in vitro, ex vivo and in vivo models and… (More)
If you would like to respond to any of the contributions in this issue or contribute to this e-Magazine, please write to the Editors at Liquid Thought innovate. evolve. accelerate.
Despite significant progress in neurosurgery and radiation therapy during the past decade, overall survivability (OS) of glioblastoma patients continues to be less than 2 years. The scope of systemic chemotherapy is greatly limited by poor drug transport across the blood brain barrier (BBB) and, thereby, suboptimal drug accumulation in glioma tissue. To… (More)